World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
79
Citations
23620
World Ranking
1680
National Ranking
828

Medicine

D-Index
81
Citations
24134
World Ranking
16651
National Ranking
8358

Overview

William E. Carson is affiliated with The Ohio State University in the United States. Their research is predominantly situated within the field of Medicine, with a strong focus on Oncology and related subfields. The scientist's work spans Oncology, Immunology, Molecular Biology, Cancer Research, and Epidemiology, reflecting a multidisciplinary approach to medical research.

The main research topics covered in their publications include Cancer Immunotherapy and Biomarkers, Immune cells in cancer, Immune Cell Function and Interaction, Lung Cancer Research Studies, Neuroendocrine Tumor Research Advances, Immunotherapy and Immune Responses, and CAR-T cell therapy research.

Frequent publication venues for William E. Carson include Journal of Clinical Oncology and Cancer Research, each with 13 publications. Other notable venues are Annals of Surgical Oncology, Psycho-Neuroendocrinology, and bioRxiv (Cold Spring Harbor Laboratory).

William E. Carson has frequently collaborated with several co-authors, notably Brooke Benner, Himanshu Savardekar, Robert Wesolowski, Emily Schwarz, and Kari Kendra.

Selected recent papers authored or co-authored by William E. Carson include:

  • Pexidartinib, a Novel Small Molecule CSF-1R Inhibitor in Use for Tenosynovial Giant Cell Tumor: A Systematic Review of Pre-Clinical and Clinical Development (2020), published in Drug Design Development and Therapy
  • Biomimetic nanoparticles deliver mRNAs encoding costimulatory receptors and enhance T cell mediated cancer immunotherapy (2021), published in Nature Communications
  • CD200 promotes immunosuppression in the pancreatic tumor microenvironment (2020), published in Journal for ImmunoTherapy of Cancer
  • Depression and anxiety in colorectal cancer patients: Ties to pain, fatigue, and inflammation (2022), published in Psycho-Oncology
  • Phase 2 study of ibrutinib in classic and variant hairy cell leukemia (2021), published in Blood

Best Publications

  • Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset

    Megan A. Cooper;Todd A. Fehniger;Sarah C. Turner;Kenneth S. Chen

  • Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.

    William E. Carson;Judith G. Giri;Matthew J. Lindemann;Michael L. Linett

  • Psychologic Intervention Improves Survival for Breast Cancer Patients: A Randomized Clinical Trial

    Barbara L. Andersen;Hae-Chung Yang;William B. Farrar;Deanna M. Golden-Kreutz

  • Psychological, Behavioral, and Immune Changes After a Psychological Intervention: A Clinical Trial

    Barbara L. Andersen;William B. Farrar;Deanna M. Golden-Kreutz;Ronald Glaser

  • A potential role for interleukin-15 in the regulation of human natural killer cell survival.

    W E Carson;T A Fehniger;S Haldar;K Eckhert

  • Cutaneous melanoma, version 2.2019

    Daniel G. Coit;John A. Thompson;Mark R. Albertini;Christopher Barker

  • Pain, depression, and fatigue: loneliness as a longitudinal risk factor.

    Lisa M. Jaremka;Rebecca R. Andridge;Christopher P. Fagundes;Catherine M. Alfano

  • Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro.

    William E. Carson;Mary E. Ross;Robert A. Baiocchi;Melanie J. Marien

  • Myeloid derived suppressor cells – a new therapeutic target in the treatment of cancer

    Robert Wesolowski;Joseph Markowitz;William E Carson

  • Melanoma, version 2.2016 clinical practice guidelines in oncology

    Daniel G. Coit;John A. Thompson;Alain Algazi;Robert Andtbacka

  • Flt3 Ligand Promotes the Generation of a Distinct CD34+Human Natural Killer Cell Progenitor That Responds to Interleukin-15

    Haixin Yu;Todd A. Fehniger;Todd A. Fehniger;Todd A. Fehniger;Pascal Fuchshuber;Pascal Fuchshuber;Pascal Fuchshuber;Karl S. Thiel;Karl S. Thiel;Karl S. Thiel

  • Distress reduction from a psychological intervention contributes to improved health for cancer patients

    Barbara L. Andersen;William B. Farrar;Deanna Golden-Kreutz;Charles F. Emery

  • Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology.

    Dan Shu;Hui Li;Yi Shu;Gaofeng Xiong

  • Social support predicts inflammation, pain, and depressive symptoms: Longitudinal relationships among breast cancer survivors

    Spenser Hughes;Lisa M. Jaremka;Catherine M. Alfano;Ronald Glaser

  • The functional characterization of interleukin-10 receptor expression on human natural killer cells.

    William E. Carson;Matthew J. Lindemann;Robert Baiocchi;Michael Linett

  • Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: Novel anti-tumor mechanisms of Cannabidiol in breast cancer

    Mohamad Elbaz;Mohd W. Nasser;Janani Ravi;Nissar A. Wani

  • Sentinel node biopsy in breast cancer.

    John M. Barnwell;Mark A. Arredondo;Daniel Kollmorgen;John F. Gibbs

  • Myeloid-Derived Suppressor Cell Inhibition of the IFN Response in Tumor-Bearing Mice

    Bethany L Mundy-Bosse;Gregory B. Lesinski;Alena C Jaime-Ramirez;Kristen Benninger

  • IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells

    Robin Parihar;Julie Dierksheide;Yan Hu;William E. Carson

  • Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor-Mediated Natural Killer Cell Function.

    Andrew Stiff;Prashant Trikha;Bethany L Mundy-Bosse;Elizabeth L McMichael

  • Signaling pathways involved in MDSC regulation.

    Prashant Trikha;William E. Carson

Frequent Co-Authors

Susheela Tridandapani
Susheela Tridandapani The Ohio State University
Michael A. Caligiuri
Michael A. Caligiuri City Of Hope National Medical Center
John C. Byrd
John C. Byrd University of Pittsburgh Cancer Institute
Janice K. Kiecolt-Glaser
Janice K. Kiecolt-Glaser The Ohio State University
Barbara L. Andersen
Barbara L. Andersen The Ohio State University
Charles L. Shapiro
Charles L. Shapiro Icahn School of Medicine at Mount Sinai
Albert de la Chapelle
Albert de la Chapelle The Ohio State University
Michael R. Grever
Michael R. Grever The Ohio State University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in branching out from Immunology into healthcare, various online nursing degrees offer accessible routes. For example, many non-nurses in Florida explore online rn programs for non nurses in florida, which allow individuals to start a nursing career without prior clinical experience.

If you’re looking to accelerate your nursing education, accelerated nursing programs near me provide intensive, fast-track options to earn your Bachelor of Science in Nursing (BSN) efficiently.

For those considering entry-level nursing roles, identifying the easy lpn programs to get into can be a strategic way to enter the field quickly, offering practical experience and a pathway to further study.

Advanced practice roles require more specialized education, but some candidates seek out which nurse practitioner program is easiest to balance their career advancement with personal commitments.

Exploring these related degrees can complement an Immunology background, broadening career prospects in healthcare and research sectors.

Best Scientists Citing William E. Carson

Trending Scientists

Recently Published Articles